Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Limosilactobacillus reuteri & Functional gastrointestinal disorder (FGIDs) / Disorders of gut-brain interaction (DGBIs)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

The study identified as NCT02865564 suggests that administering probiotics to newborns during and following antibiotic therapy could potentially reduce the adverse impacts of antibiotics on gut function during this critical stage of human growth, warranting additional research (1)

References:

(1) Krivec et al. 2024 Benef Microbes 16(2): 157-169

…

References (Sources)

Effects of Limosilactobacillus reuteri DSM 17938 in neonates exposed to antibiotics: a randomised controlled trial
Krivec et al. 2024 Benef Microbes 16(2): 157-169

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!